Cargando…

Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma

E-cadherin is well known as a growth and invasion suppressor and belongs to the large cadherin family. Loss of E-cadherin is widely known as the hallmark of epithelial-to-mesenchymal transition (EMT) with the involvement of transcription factors such as Snail, Slug, Twist and Zeb1/2. Tumor cells und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Xiaoxiao, Jin, Shengxi, Li, Yirun, Khadaroo, Parikshit Asutosh, Dai, Yili, He, Lifeng, Zhou, Daizhan, Lin, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801489/ https://www.ncbi.nlm.nih.gov/pubmed/31802937 http://dx.doi.org/10.2147/CMAR.S225606

Ejemplares similares

Duplication of the extrahepatic bile duct: A case report and review of the literatures
por: Fan, Xiaoxiao, et al.
Publicado: (2018)

Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients
por: Fan, Xiaoxiao, et al.
Publicado: (2020)

Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma
por: He, Lifeng, et al.
Publicado: (2019)

CSF1R methylation is a key regulatory mechanism of tumor-associated macrophages in hepatocellular carcinoma
por: Cui, Bin, et al.
Publicado: (2020)

Methylation patterns of RASA3 associated with clinicopathological factors in hepatocellular carcinoma
por: Lin, Hui, et al.
Publicado: (2018)

The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma
por: Fan, Xiaoxiao, et al.
Publicado: (2018)

Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
por: Zhong, Cheng, et al.
Publicado: (2021)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
por: Li, Duguang, et al.
Publicado: (2023)

Hypomethylation status of miR-657 promoter region as biomarker for diagnosis of hepatocellular carcinoma: a retrospective study
por: Shi, Zhaoqi, et al.
Publicado: (2022)

A Comparison Between the Prognosis of Simultaneous and Salvage Radical Resection in Incidental Gallbladder Cancer
por: He, Shilin, et al.
Publicado: (2020)

The paradoxical functions of long noncoding RNAs in hepatocellular carcinoma: Implications in therapeutic opportunities and precision medicine
por: Li, Duguang, et al.
Publicado: (2020)

A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass
por: Gu, Lihu, et al.
Publicado: (2020)

Usefulness of the estimation of physiologic ability and surgical stress (E-PASS) system for prediction of complication and prognosis in hepatocellular carcinoma patients after hepatectomy
por: Dai, Yili, et al.
Publicado: (2022)

Risk Factors for Duodenal Stump Leakage after Laparoscopic Gastrectomy for Gastric Cancer
por: Gu, Lihu, et al.
Publicado: (2020)

Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer
por: Hu, Yue, et al.
Publicado: (2018)

Promoter Methylation of E-cadherin in Hepatocellular Carcinomas and Dysplastic Nodules
por: Kwon, Ghee Young, et al.
Publicado: (2005)

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
por: Gu, Lihu, et al.
Publicado: (2019)

Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis
por: Chen, Jiang, et al.
Publicado: (2014)

Negative Correlation of LIV-1 and E-Cadherin Expression in Hepatocellular Carcinoma Cells
por: Shen, Rongxi, et al.
Publicado: (2013)

Global Trends in Research of Lipid Metabolism in T lymphocytes From 1985 to 2022: A Bibliometric Analysis
por: Chen, Peng, et al.
Publicado: (2022)

Cell membrane-coated human hair nanoparticles for precise disease therapies
por: Zhang, Yiyin, et al.
Publicado: (2022)

Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein
por: Laurson, Joanna, et al.
Publicado: (2010)

Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis
por: Mo, Jiahang, et al.
Publicado: (2020)

The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis
por: Chen, Jingjie, et al.
Publicado: (2020)

ESR1 Regulates the Obesity- and Metabolism-Differential Gene MMAA to Inhibit the Occurrence and Development of Hepatocellular Carcinoma
por: Zhang, Yiyin, et al.
Publicado: (2022)

Autoregulation of E-cadherin expression by cadherin–cadherin interactions: the roles of β-catenin signaling, Slug, and MAPK
por: Conacci-Sorrell, Maralice, et al.
Publicado: (2003)

Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
por: Hashiguchi, Motoyuki, et al.
Publicado: (2013)

Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
por: Yi, Kijong, et al.
Publicado: (2016)

G9a and histone deacetylases are crucial for Snail2‐mediated E‐cadherin repression and metastasis in hepatocellular carcinoma
por: Hu, Yue, et al.
Publicado: (2019)

C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11
por: Li, Duguang, et al.
Publicado: (2022)

RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis
por: Gan, Wen-Juan, et al.
Publicado: (2016)

Effects of UPF1 expression on EMT process by targeting E-cadherin, N-cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line
por: Li, Yawei, et al.
Publicado: (2019)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
por: Loh, Chin-Yap, et al.
Publicado: (2019)

Anti-Cadherin-17 Antibody Modulates Beta-Catenin Signaling and Tumorigenicity of Hepatocellular Carcinoma
por: Wang, Yonggang, et al.
Publicado: (2013)

Tissue expression of β-catenin and E- and N-cadherins in chronic hepatitis C and hepatocellular carcinoma
por: Kasprzak, Aldona, et al.
Publicado: (2017)

E-cadherin and aquaporin 1 co-expression analysis in hepatocellular carcinoma: a pilot study
por: Ciurea, Ana-Maria, et al.
Publicado: (2021)

E-Cadherin Signaling in Salivary Gland Development and Autoimmunity
por: Sisto, Margherita, et al.
Publicado: (2022)

Genetic and epigenetic characteristics of human multiple hepatocellular carcinoma
por: Taniguchi, Kazuya, et al.
Publicado: (2010)

Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo
por: Jiao, W, et al.
Publicado: (2002)

Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas
por: YUE, YUAN, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3c139qm20hudhsndvom3954mkp